Just curious, So based on the below statement....it implies to me ONLY IFAS attains/hits any of those milestones...then we're entitled to something $$.. correct? What IF they don't meet any of those intented milestones in the next 1-2 or even 10 yrs? Do we have any contengency plan/outlet? Marked in RED caught my eye. Am I making any sense? ;) I appreciate your thoughts!
"As part of the agreement, Innovation is eligible to receive over $24M in initial and milestone-based payments, and a 6 percent royalty (net sales) based on the successful marketing of Brilacidin for UP/UPS.The agreement also includes a Right of First Refusal for Brilacidin for the treatment of more extensive forms of IBD "